Cable Hill Partners’s NxStage Medical Inc. NXTM Stock Holding History

Cable Hill Partners’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$6K	–	859
2018 Q4	$6K	Hold	200	–	–	﹤0.01%	548
2018 Q3	$6K	Hold	200	–	–	﹤0.01%	551
2018 Q2	$6K	Hold	200	–	–	﹤0.01%	637
2018 Q1	$5K	Hold	200	–	–	﹤0.01%	693
2017 Q4	$5K	Hold	200	–	–	﹤0.01%	760
2017 Q3	$6K	Sell	200 -611	-75%	-$16.3K	﹤0.01%	738
2017 Q2	$20K	Buy	811 +137	+20%	+$3.39K	0.01%	266
2017 Q1	$18K	Buy	674 +474	+237%	+$13.1K	0.01%	274
2016 Q4	$5K	Hold	200	–	–	﹤0.01%	565
2016 Q3	$5K	Hold	200	–	–	﹤0.01%	591
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	521
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	532
2015 Q4	$5K	Hold	200	–	–	﹤0.01%	480
2015 Q3	$4K	Buy	+200	New	+$3.21K	﹤0.01%	558

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Cable Hill Partners's NXTM Position: Q1 2019 in Review

Cable Hill Partners sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 200 shares — an estimated $6K sold.

Cable Hill Partners first reported a position in NXTM in Q3 2015 and held it in 14 quarters. The position peaked at $20K in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Cable Hill Partners reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Cable Hill Partners sold 200 NxStage Medical Inc. shares in Q1 2019, an estimated $6K.
Cable Hill Partners first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 14 quarters.
Cable Hill Partners's NxStage Medical Inc. position peaked at $20K in Q2 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Cable Hill Partners's 13F filing for Q1 2019, filed 10 May 2019.